Market closed
Bioage Labs Inc/$BIOA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Bioage Labs Inc
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.
Ticker
$BIOA
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
63
Website
Bioage Labs Inc Metrics
BasicAdvanced
$152M
-
-$6.63
-
-
Price and volume
Market cap
$152M
52-week high
$4.68
52-week low
$2.88
Average daily volume
307K
Financial strength
Current ratio
12.857
Quick ratio
12.758
Long term debt to equity
0.774
Total debt to equity
2.694
Interest coverage (TTM)
-33.04%
Management effectiveness
Return on assets (TTM)
-25.44%
Return on equity (TTM)
-50.35%
Valuation
Price to book
0.47
Price to tangible book (TTM)
0.47
Price to free cash flow (TTM)
-0.874
Growth
Earnings per share change (TTM)
-82.63%
Bioage Labs Inc News
AllArticlesVideos
BioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024
GlobeNewsWire·1 month ago
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in BioAge Labs, Inc. Lawsuit - BIOA
Accesswire·2 months ago
Levi & Korsinsky Notifies BioAge Labs, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – BIOA
Accesswire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Bioage Labs Inc stock?
Bioage Labs Inc (BIOA) has a market cap of $152M as of April 28, 2025.
What is the P/E ratio for Bioage Labs Inc stock?
The price to earnings (P/E) ratio for Bioage Labs Inc (BIOA) stock is 0 as of April 28, 2025.
Does Bioage Labs Inc stock pay dividends?
No, Bioage Labs Inc (BIOA) stock does not pay dividends to its shareholders as of April 28, 2025.
When is the next Bioage Labs Inc dividend payment date?
Bioage Labs Inc (BIOA) stock does not pay dividends to its shareholders.
What is the beta indicator for Bioage Labs Inc?
Bioage Labs Inc (BIOA) does not currently have a Beta indicator.